The partnership includes a joint venture firm, maxon dental, which will produce dental implant components by using CIM process instead of conventional cutting techniques.

Based near Freiburg, the JV firm will develop and produce CIM components for Straumann.

Under the deal, Straumann will hold 49% stake in the JV firm, subject to approval by the German Federal Cartel Office. It is also provided with an option to increase equity stake to full ownership in 2026.

Financial terms of the deal have not been disclosed.

Straumann CEO Marco Gadola said: ‘There are few – if any – technology providers in the world that can equal maxon motor with regard to innovation, expertise and reliability in CIM.

“Combining our strengths in dentistry with their technology leadership, the initial goal of our joint venture is to make ceramic implant treatments easier for dentists and more affordable for patients who want highly esthetic, metal-free solutions

We expect to launch our first CIM components in the near term – providing that the outcome of laboratory and clinical programs and regulatory applications are favourable.”

Based in Sachseln, maxon motor produces small DC drive systems that are used in insulin and cardiac pumps, surgical power tools and humanoid robots.

Based in Basel, Strauman develops and produces dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions to prevent tooth loss.